Market Access Feasibility Assessment
Task:
Assess market potential, epidemiology, and treatment landscape
Task:
Assess market potential, epidemiology, and treatment landscape
Client:
British pharmaceutics company
Region:
Ukraine, Armenia, Azerbaijan, Georgia, Kazakhstan, Uzbekistan + 2 other countries
Project scope:
- Assessment of the possibility for the Target product of getting the status of an orphan drug for three indications—Lennox-Gastaut-Syndrome, Dravet Syndrome, and Tuberous Sclerosis.
- Analysis of disease management and treatment practices in countries from the scope.
- Outlining patient flows for three indications in all countries.
- Analysis of the market landscape, competitive products within the therapeutic areas, and prescription patterns.
- Pricing analysis of products prescribed within the three indications.
- The decision-making process for innovative products in all countries.
- Available pathways for early access (if possible).
Indications in focus:
Neurology / Epilepsy:
- Lennox-Gastaut-Syndrome
- Dravet Syndrome
- Tuberous Sclerosis
Deliverables:
- A comprehensive report covering 8 countries and three indications.
Project
leads

Download
our Brochure
our Brochure